IVF Versus LOD in Women With CC Resistant PCOS

Sponsor
Mohamed Sayed Abdelhafez (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02456792
Collaborator
(none)
0
2
2
16
0
0

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the efficacy of in vitro fertilization (IVF) versus laparoscopic ovarian drilling (LOD) in infertile women having clomiphene citrate (CC) resistant polycystic ovarian syndrome (PCOS).

Condition or Disease Intervention/Treatment Phase
  • Procedure: IVF
  • Procedure: LOD
Phase 4

Detailed Description

Women will be randomly divided into two groups; IVF group and LOD group. Women in the IVF group will undergo one full IVF cycle. Women in the LOD group will be subjected to LOD followed by ovarian stimulation if spontaneous ovulation does not occur within 2 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
In Vitro Fertilization Versus Laparoscopic Ovarian Drilling in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome
Study Start Date :
Jan 1, 2016
Anticipated Primary Completion Date :
Apr 1, 2017
Anticipated Study Completion Date :
May 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: IVF group

Women will undergo one full IVF cycle

Procedure: IVF
Women will undergo one IVF cycle
Other Names:
  • Intracytoplasmic sperm injection (ICSI)
  • Active Comparator: LOD group

    Women will be subjected to LOD followed by ovarian stimulation if spontaneous ovulation does not occur within 2 months

    Procedure: LOD
    Women will be subjected to LOD followed by ovarian stimulation if spontaneous ovulation does not occur within 2 months
    Other Names:
  • Laparoscopic ovarian diathermy
  • Outcome Measures

    Primary Outcome Measures

    1. Live birth rate [9 months]

      Number of live births divided by the number of women

    Secondary Outcome Measures

    1. Clinical pregnancy rate [6-8 weeks gestational age]

      Number of clinical pregnancies divided by the number of women

    2. Multifetal pregnancy rate [12 weeks gestational age]

      Number of multifetal pregnancies divided by the number of clinical pregnancies

    3. Miscarriage rate [12 weeks gestational age]

      Number of first trimester miscarriages (before 12 weeks gestational age) divided by the number of clinical pregnancies

    4. Incidence of early ovarian hyperstimulation syndrome (OHSS) [Within 9 days of final triggering of oocyte maturation]

      Incidence of OHSS within 9 days of final triggering of oocyte maturation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 35 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Infertile women with PCOS as defined by the Rotterdam criteria.

    • CC resistance (defined as failure of ovulation after receiving 150 mg/day of CC for 5 consecutive days per cycle, for at least 3 consecutive cycles).

    Exclusion Criteria:
    • Age < 20 or > 35 years.

    • Presence of any infertility factor other than anovulatory PCOS.

    • Previous history of ovarian surgery or surgical removal of one ovary.

    • Previous exposure to cytotoxic drugs or pelvic irradiation.

    • Oral hypoglycemic or hormonal therapy either currently or in the preceding 3 months.

    • Metabolic or hormonal abnormalities.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fertility Care Unit (FCU) in Mansoura University Hospital Mansoura Dakahlia Egypt 35111
    2 Private fertility care centers Mansoura Dakahlia Egypt

    Sponsors and Collaborators

    • Mohamed Sayed Abdelhafez

    Investigators

    • Principal Investigator: Ahmed Gibreel, Dr, Mansoura University
    • Study Director: Mohamed S Abdelhafez, Dr, Mansoura University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mohamed Sayed Abdelhafez, Dr, Mansoura University
    ClinicalTrials.gov Identifier:
    NCT02456792
    Other Study ID Numbers:
    • AG1
    First Posted:
    May 29, 2015
    Last Update Posted:
    May 10, 2017
    Last Verified:
    May 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by Mohamed Sayed Abdelhafez, Dr, Mansoura University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 10, 2017